On This Page
Part 2 of 3: Four Factors That Shape Healthcare Innovation
What separates a promising healthcare technology from one that successfully reaches patients and becomes part of everyday clinical care?
In Part 1 of our series, we explored how early detection and prevention can improve patient outcomes when clinicians have the information, tools, and processes needed to take action.
But bringing those innovations into practice requires more than clinical promise. Founders must navigate regulatory requirements, establish viable business models, and demonstrate that healthcare providers can successfully adopt their technologies.
At the AZBio White Hat Life Science Investor Conference, Todd Perman and Jacque Sokolov, MD discussed four critical factors that influence whether healthcare innovations succeed: clinical evidence, regulatory requirements, business models, and provider adoption.
▶ Watch Jacque introduce the four evaluation factors (7:29)
Together, these factors provide a practical framework for healthcare founders developing new solutions, providers evaluating emerging technologies, and investors assessing commercialization potential.
Establish a Strong Clinical Foundation
Every successful healthcare innovation begins with a clearly defined clinical need.
What problem does the technology address? Which patients stand to benefit? What evidence demonstrates its effectiveness, and how could it improve existing standards of care?
For founders, answering these questions early helps guide product development, clinical validation, and the evidence needed to support adoption. Demonstrating that a technology can generate meaningful information is only part of the equation. Companies must also show how that information can support clinical decisions and improve patient care.
For healthcare providers, understanding a technology's intended use, supporting evidence, and limitations is essential to determining where it fits within clinical practice.
For investors, clinical validation provides an important foundation for evaluating both the opportunity and the risks ahead. Strong evidence, a well-defined patient population, and a credible development plan can help distinguish technologies with meaningful potential from those that still face substantial uncertainty.
Navigate the Regulatory Landscape
Regulatory strategy plays a critical role in determining how and when healthcare technologies can enter the market.
Requirements vary depending on the technology, its intended use, and the countries or healthcare markets where a company plans to operate. Understanding these requirements early helps companies anticipate development timelines, allocate resources, and establish realistic commercialization milestones.
For founders, regulatory planning should be integrated into product development and clinical validation from the beginning.
For investors, the focus extends beyond achieving a single regulatory milestone. Evaluating a company's readiness means understanding the remaining requirements, potential risks, and resources needed to advance toward commercialization.
Regulatory progress can create important opportunities, but companies must also prepare for the clinical and commercial work required after authorization.
Build a Sustainable Business Model
A technology can demonstrate significant clinical potential and still struggle to achieve commercial success without a viable business model.
Healthcare companies must identify who will purchase their technology, who will pay for its use, and what value it delivers to each stakeholder. Health systems, insurers, employers, clinicians, and patients may evaluate that value through different financial and clinical priorities.
For founders, developing a sustainable business model means connecting clinical value to a realistic path toward revenue, reimbursement, and long-term growth.
For providers, implementation costs, operational resources, and reimbursement considerations influence whether a new technology is practical to introduce into everyday care.
For investors, understanding these dynamics helps assess a company's ability to generate revenue, manage capital requirements, and scale beyond initial deployments.
A strong commercialization strategy accounts for both the financial realities of healthcare delivery and the resources required to bring a technology to market.
Create a Clear Path to Provider Adoption
Regulatory authorization and clinical validation are important milestones, but neither guarantees that healthcare organizations will adopt a new technology.
During the White Hat discussion, Todd emphasized the importance of aligning providers and payers as companies move toward commercialization.
▶ Watch Todd discuss why regulatory progress alone does not create adoption (29:09)
For founders, adoption planning requires understanding how a technology fits into existing clinical workflows, who will use it, and what changes may be needed to support implementation.
For providers, the priority is determining whether the technology addresses a meaningful need while fitting within the operational demands of patient care.
For investors, provider engagement can offer valuable insight into market demand, implementation challenges, and the potential for broader commercial adoption.
Involving clinicians throughout development helps companies identify barriers early, refine their solutions, and build stronger pathways into healthcare organizations.
Connecting the Four Factors
Clinical evidence, regulatory strategy, business models, and provider adoption are closely connected. Decisions in one area can directly influence progress in another.
Clinical requirements can shape development timelines and capital needs. Reimbursement considerations can influence market strategy. Provider feedback can reveal operational challenges that affect implementation costs and adoption.
Geography introduces additional considerations. During the discussion, Dr. Sokolov explained that these four factors remain relevant across international markets, even as healthcare systems, regulatory structures, and financial incentives differ.
▶ Watch Jacque discuss evaluating international market opportunities (16:32)
For founders, understanding these connections supports more informed decisions about where to focus resources and how to sequence commercialization efforts.
For investors, evaluating the four factors together provides a more complete picture of a company's readiness, potential risks, and opportunities for growth.
At Seed Healthcare, this integrated perspective informs how emerging healthcare technologies are evaluated and supported. By combining investment capital with clinical expertise, healthcare leadership, and provider relationships, Seed works with portfolio companies to address commercialization challenges and accelerate pathways to adoption.
Successful healthcare innovation requires more than developing a promising technology. It requires a coordinated strategy that connects clinical value, regulatory progress, financial sustainability, and real-world implementation.
Coming Next in the Series
In Part 3, we'll explore what healthcare founders should look for in an investment partner and why commercialization experience, clinical relationships, and hands-on strategic support can be just as important as capital.